ArticleMedicine2018
Colonic metastasis from breast carcinoma detection by CESM and PET/CT: A case report.
Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Colonic metastasis from breast carcinoma: A case report and systematic review of a rare clinical scenario.International journal of colorectal disease · 2026Pooled it
- Breast cancer metastasis to the colon mimicking primary colorectal carcinoma.EJNMMI reports · 2026Article
- Article
- Metastasizing to the colon from triple-negative breast cancer: A case report and review of literature.World journal of gastrointestinal oncology · 2025Article
- Review
- A case of breast cancer with extensive colon metastasis.DEN open · 2023Article
- Ascending colon metastasis after breast cancer surgery: a case report and literature review.Gland surgery · 2023Article
- Special Issue "Advancement in Breast Diagnostic and Interventional Radiology".Diagnostics (Basel, Switzerland) · 2022Article
- Intestinal metastasis from breast cancer: Presentation, treatment and survival from a systematic literature review.World journal of clinical oncology · 2021Article
- Widespread Metastasis to the Stomach 10 Years After Primary Breast Cancer: A case report and review of the literature.Medicine · 2020Review
- Rare sites of breast cancer metastasis: a review.Translational cancer research · 2019Review
- Colonic Metastasis from Breast Cancer: A Case Report and Review of the Literature.In vivo (Athens, Greece)Review
- Colorectal Metastasis from Ovarian Neoplasm Mimicking Primary Colon Cancer.Case reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMetastatic spread in invasive lobular carcinoma (ILC) of breast mainly occurs in bones, gynecological organs, peritoneum, retroperitoneum, and gastrointestinal (GI) tract. Metastases to the GI tract may arise many years after initial diagnosis and can affect the tract from the tongue to the anus, stomach being the most commonly involved site. Clinical presentations are predominantly nonspecific, and rarely asymptomatic. CEA, CA 15-3, and CA 19-9 may be informative for symptomatic patients who have had a previous history of breast cancer. CASE PRESENTATION: We introduce the case of asymptomatic colonic metastasis from breast carcinoma in a 67-year-old woman followed-up for Luminal A ILC. Diagnosis was performed through positron emission tomography/computed tomography (PET/CT) scan and contrast-enhancement spectral mammography (CESM), steering endoscopist to spot the involved intestinal tract and in ruling out further dissemination in the breast parenchyma.
conclusionIn colonic metastases, tumor markers might not be totally reliable. In asymptomatic cases, clinical conditions might be underappreciated, missing local or distant recurrence. CT and PET/CT scan might be useful in diagnosing small volume diseases, and steering endoscopist toward GI metastasis originating from the breast. CESM represents a tolerable and feasible tool that rules out multicentricity and multifocality of breast localization. Moreover, particular patients could tolerate it better than magnetic resonance imaging (MRI).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.